help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 6, 2006
Endocrinology, doi:10.1210/en.2005-1309
A more recent version of this article appeared on July 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/7/3307    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yogo, K.
Right arrow Articles by Takeya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yogo, K.
Right arrow Articles by Takeya, T.

Submitted on October 14, 2005
Accepted on March 24, 2006

SH2-containing 5'-inositol phosphatase (SHIP) localizes to podosomes and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts

Keiichiro Yogo, Megumi Mizutamari, Kazuta Mishima, Hiromi Takenouchi, Norihiro Ishida-Kitagawa, Takehiko Sasaki, and Tatsuo Takeya*

Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0192; Division of Microbiology, Department of Pathology and Immunology, Akita University School of Medicine, 1-1-1 Hondo, Akita, 010-8543

* To whom correspondence should be addressed. E-mail: ttakeya{at}bs.naist.jp.

c-Src plays an important role in bone resorption by osteoclasts. Here, we show using wild-type and ship-/- osteoclasts that SH2-containing 5'-inositol phosphatase (ship) appeared to negatively regulate bone resorption activated by c-Src. SHIP was found to localize to podosomes under the influence of c-Src, and the presence of either the amino-terminal region comprising the SH2 domain or the carboxyl-terminal region was sufficient for its localization. Although SHIP lacking a functional SH2 domain was still found in podosomes, it could not rescue the hyper-bone resorbing activity and hyper-sensitivity to RANKL in ship-/- osteoclasts, suggesting that the localization of SHIP to podosomes per se was not sufficient and the SH2 domain was indispensable for its function. Cas and c-Cbl, known to function in podosomes of osteoclasts, were identified as novel proteins binding to the SHIP SH2 domain by mass spectrometric analysis and this interaction appeared to be dependent on the Src kinase activity. These results demonstrate that c-Src enhances the translocation of SHIP to podosomes and regulates its function there through the SH2 domain, leading to an attenuation of bone resorption.


Key words: osteoclasts • c-Src • SHIP • podosome • bone resorption







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society